Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03368625
What this trial is testing

Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases

Who this might be right for
Brain Metastases
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Looking for participantsNCT05872347
What this trial is testing

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Who this might be right for
Breast Cancer Brain Metastases
Shanghai Pharmaceuticals Holding Co., Ltd 52
Testing effectiveness (Phase 2)Ended earlyNCT02974803
What this trial is testing

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Canadian Cancer Trials Group 6
Early research (Phase 1)Study completedNCT04396717
What this trial is testing

Safety Study of Pritumumab in Brain Cancer

Who this might be right for
Malignant Primary Brain TumorsBrain Metastases, Adult
Nascent Biotech 15
Testing effectiveness (Phase 2)Ended earlyNCT01721603
What this trial is testing

Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

Who this might be right for
BRAFV600E Melanoma Patients
University of California, San Francisco 2
Not applicableLooking for participantsNCT05033691
What this trial is testing

Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Who this might be right for
NSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more
Hadassah Medical Organization 162
Large-scale testing (Phase 3)Looking for participantsNCT05768490
What this trial is testing

Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

Who this might be right for
Brain MetastasesRadiotherapyEGFR Activating Mutation
Sun Yat-sen University 232
Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Testing effectiveness (Phase 2)UnknownNCT04211090
What this trial is testing

Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC

Who this might be right for
Non-squamous Non-small-cell Lung CancerBrain Metastases
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Ended earlyNCT04461418
What this trial is testing

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases

Who this might be right for
Brain Metastases, Adult
AHS Cancer Control Alberta 2
Early research (Phase 1)Active Not RecruitingNCT01843413
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases

Who this might be right for
Tumors Metastatic to BrainUnspecified Adult Solid Tumor
Case Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT02230306
What this trial is testing

Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases

Who this might be right for
Active Melanoma Brain Metastases
Melissa Burgess, MD 5
Not applicableStudy completedNCT00795678
What this trial is testing

Chemotherapeutic Agents in Brain/Breast

Who this might be right for
Breast CancerMetastatic Cancer
Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Testing effectiveness (Phase 2)Study completedNCT02662725
What this trial is testing

Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases

Who this might be right for
MelanomaBrain Metastasis
University Hospital, Lille 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177950
What this trial is testing

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesLeptomeningeal Metastasis
Peking University Cancer Hospital & Institute 51
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Testing effectiveness (Phase 2)Study completedNCT01497808
What this trial is testing

RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA

Who this might be right for
Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)UnknownNCT01755624
What this trial is testing

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Who this might be right for
1-5 Brain Metastases From Non-Small Cell Lung Cancer
NovoCure Ltd. 18
Next Page